Condensed Consolidated Statements Of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues:
Net sales	$ 3,029.5	$ 2,676.2	$ 7,745.5	$ 6,887.8
Other revenues	27.6	19.0	63.6	50.8
Total revenues	3,057.1	2,695.2	7,809.1	6,938.6
Cost of sales	1,773.8	1,379.9	4,447.1	3,785.1
Gross profit	1,283.3	1,315.3	3,362.0	3,153.5
Operating expenses:
Research and development	199.1	174.8	632.2	512.9
Selling, general and administrative	656.9	537.1	1,787.6	1,584.5
Litigation settlements and other contingencies, net	558.0	2.3	556.4	19.1
Total operating expenses	1,414.0	714.2	2,976.2	2,116.5
(Loss) earnings from operations	(130.7)	601.1	385.8	1,037.0
Interest expense	144.4	95.1	305.0	268.5
Other expense, net	50.2	50.9	184.0	71.4
(Loss) earnings before income taxes and noncontrolling interest	(325.3)	455.1	(103.2)	697.1
Income tax (benefit) provision	(205.5)	26.5	(165.7)	44.0
Net (loss) earnings	(119.8)	428.6	62.5	653.1
Net earnings attributable to the noncontrolling interest	0.0	0.0	0.0	(0.1)
Net (loss) earnings attributable to Mylan N.V. ordinary shareholders	$ (119.8)	$ 428.6	$ 62.5	$ 653.0
(Loss) earnings per ordinary share attributable to Mylan N.V. ordinary shareholders:
Basic (in USD per share)	$ (0.23)	$ 0.87	$ 0.12	$ 1.40
Diluted (in USD per share)	$ (0.23)	$ 0.83	$ 0.12	$ 1.32
Weighted average ordinary shares outstanding:
Basic	523.6	490.5	505.9	466.2
Diluted	523.6	514.0	515.2	493.2